NEWS
October 6, 2010
J&J Sticks to $2.4 Billion Bid for Crucell
Crucell said it would recommend U.S. personal care group Johnson & Johnson's unchanged cash offer of 24.75 euros per share for the Dutch biotech as one shareholder said he would not sell at that price...
|
|
|
|
If you already have a OnePass account, you can use it to access Business Law Currents as part of our free trial
program. If you don’t have a OnePass account, click on the link to the left to create one. You can then use this
OnePass account to access Business Law Currents as part of our free trial.
|
|